Center-Authored Papers

Filters: Author is Karp, Judith E  [Clear All Filters]
B
Baden LR, Bensinger WI, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI et al..  2012.  Prevention and treatment of cancer-related infections.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(11):1412-45. Abstract
K
Karp JE, Garrett-Mayer EL, Estey EH, Rudek MA, Smith DB, Greer JM, Drye MD, Mackey K, Dorcy KS, Gore SD et al..  2012.  Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.. Haematologica. Abstract
S
Schimmer AD, Estey EH, Borthakur G, Carter BZ, Schiller GJ, Tallman MS, Altman JK, Karp JE, Kassis J, Hedley DW et al..  2009.  Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4741-6. Abstract
Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI et al..  2008.  Prevention and treatment of cancer-related infections.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):122-74.